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Original Study
Characteristics of Mid-Frequency Sensorineural Hearing
Loss Progression
Jack Birkenbeuel, Mehdi Abouzari, Khodayar Goshtasbi, Omid Moshtaghi,
yRonald Sahyouni, Afsheen Moshtaghi, Dillon Cheung, Donna Gelnett,
Harrison W. Lin, and yHamid R. Djalilian
Department of Otolaryngology–Head and Neck Surgery; and yDepartment of Biomedical Engineering,
University of California, Irvine, California
Objectives: To characterize the progression of mid-fre-
quency sensorineural hearing loss (MFSNHL) over time.
Methods: A retrospective chart review spanning 2012 to
2017 was performed at a tertiary care audiology and
neurotology center. Our cohort included 37 patients met the
criteria for MFSNHL also known as ‘‘cookie bite hearing
loss.’’ It was defined as having a 1, 2, and 4 kHz average
pure tone audiometry greater than 10 dB in intensity
compared with the average threshold at 500 Hz and 8 kHz.
Results: Average age at initial presentation was 11.8 years
(range, 8 mo to 70 yr). Across all individuals, the average
mid-frequency threshold was 47 dB, compared with 27 dB at
500 Hz and 8 kHz. Twenty-three patients (62%) had multiple
audiograms with 4-year median follow up time. Average
values across all frequencies (0.5, 1, 2, 4, 8 kHz) in the
initial audiogram was 37 dB, compared with an average of
39 dB demonstrated on final audiogram. Of those with serial
audiograms, only five patients demonstrated threshold
changes of 10 dB or more. Of these five patients, only one
was found to have clinical worsening of MFSNHL.
Conclusions: MFSNHL is an uncommon audiometric find-
ing with unspecified long-term outcomes. We demonstrated
that most patients (96%) with MFSNHL do not experience
clinical worsening of their hearing threshold over
almost 4 years of follow up. Future prospective studies
aimed at collecting longer-term data are warranted to further
elucidate the long-term trajectory of MFSNHL patients.
Key Words: Audiometry—Cookie bite hearing loss—Mid-
frequency sensorineural hearing loss—Pediatric.
Otol Neurotol 40:e497–e502, 2019.
Mid-frequency sensorineural hearing loss (MFSNHL)
is an uncommon audiometric finding with a reported
prevalence of 0.7% (1). Its characteristic appearance is
often described as U-shaped, saucer or cookie bite shape,
making it easily recognized on audiogram. MFSNHL is
characterized by an average pure tone threshold of 1, 2,
and 4 kHz that is greater than the threshold at 0.5 and
8 kHz by at least 10 dB (2). Numerous etiologies have
been proposed for MFSNHL, including dominant non-
syndromic familial deafness, congenital deafness associ-
ated with Turner’s syndrome, bilateral congenital SNHL
with fluctuant hearing and episodic vertigo, and small
vestibular schwannomas (3–6).
MFSNHL is most often due to a variety of genetic
mutations, with a variation of the TECTA gene (encodes
alpha-tectorin) cited as the most frequent cause (7). Despite
the numerous proposed etiologies, the long-term conse-
quences of MFSNHL remain underreported. Only one
study in the literature has described the long-term prognos-
tic and clinical outcomes of MFSNHL (1). However, no
study to date has characterized MFSNHL patients over time
with serial audiograms. As such, we aimed to report the
long-term outcomes of MFSNHL patients at our institution.
METHODS
A retrospective chart review spanning 2012 to 2017 was
performed with Institutional Review Board approval at a ter-
tiary care audiology and neurotology center. MFSNHL was
identified when the average pure tone thresholds of 1, 2, and
4 kHz were 10 dB greater than the average of thresholds at 0.5
and 8 kHz. To exclude audiograms with classic ‘‘noise
notches,’’ patients with worst hearing at 4 kHz haven’t been
included in the cohort. Chart review did not reveal any included
patients to have suffered from loud noise, explosion, or head
trauma leading to sudden hearing loss. All patients were seen by
an audiologist and received comprehensive audiologic testing
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including audiogram, otoacoustic emissions (OAEs), speech
recognition threshold (SRT), word recognition score (WRS),
and otoscopic examination. If there was a difference between
the bone conduction and air-conduction threshold, the bone
conduction threshold was used. All patients included had
normal otoscopic examination and normal tympanometry at
226 Hz. The first audiogram of each patient was used to
diagnose MFSNHL. The difference in MFSNHL was clinically
significant if hearing threshold changed by 10 dB or more from
first to last audiogram in patients receiving serial audiograms.
Clinically significant serial audiograms were then reviewed by
the senior author (H.D.) and assessed to determine the validity
of the clinical mid-frequency hearing change over time. All
statistical analyses were performed using PASW 18.0 (SPSS
Inc., Chicago, IL). A p value of 0.05 or less was considered
statistically significant.
RESULTS
Overall, 37 patients met criteria for MFSNHL. Of
those, 20 (54%) were men with an average age of
11.8 12.3 years (range, 8 mo–70 yr). This cohort is
composed of mostly pediatric patients, with only two
patients above the age of 16, at 45 and 70 years of age.
Although etiology was not assessed, five (14%) endorsed
a family history of MFSNHL, five (14%) had a docu-
mented history of otitis media, while seven (19%) had
previously undergone myringotomy and tube placement
(Table 1). Average SRT and WRS in all MFSNHL
patients were 30 dB and 90%, respectively. Across all
individuals, average mid-frequency threshold was 47 dB
compared with 27 dB measured at 500 Hz and 8 kHz
averages ( p< 0.01). Figure 1 demonstrates a box plot
of all the audiograms in the study. Bilateral MFSNHL
TABLE 1. Characteristics of all 37 mid-frequency
sensorineural hearing loss patients
Age at diagnosis (meanSD) 11.8 12.3 years
No. of male patients 20 (54%)
Right ear hearing loss only 5 (14%)
Left ear hearing loss only 5 (14%)
Bilateral MFSNHL 27 (73%)
Age of patients with family history
of hearing loss (meanSD)
8.5 5.7 years
No. of patients with family history
of hearing loss
5 (14%)
History of myringotomy and
tube placement
7 (19%)
History of otitis media 5 (14%)
Average SRT of all audiograms 30 dB
Average WRS of all audiograms 90%
No. of patients with serial audiograms 23
Follow-up duration in patients with
serial audiograms (meanSD)
3.7 2.4 years
MFSNHL indicates mid-frequency sensorineural hearing loss; SD,
standard deviation; SRT, speech recognition threshold; WRS, word
recognition score.
FIG. 1. The distribution of all audiograms included in the cohort. The horizontal line in themiddle of each box represents the respectivemedian,
and the ‘‘’’ indicates themean.Whiskers represent the range(minimumtomaximum)unless there isanoutlier (circles).Outliersaredefinedasany
data points exceeding 1.5 times of interquartile range (between quartile 1 and 3) below or beyond the 1st or 3rd quartile, respectively.
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was observed in 27 (73%) patients. Average SRT was
30 dB both in patients who demonstrated bilateral and
unilateral MFSNHL.
Serial audiograms were obtained and reviewed in 23
(62%) patients, allowing the study team to track changes
in hearing loss for an average time of 3.7 2.4 years
(median, 4 yr). The average thresholds of all frequencies
(0.5, 1, 2, 4, 8 kHz) on initial and final audiograms were
37 and 39 dB, respectively ( p¼ 0.54). Over time, five
patients experienced mid-frequency changes greater than
or equal to the 10 dB. These changes were reviewed for
clinical significance by the senior author. In total, for
three patients, thresholds worsened over time by 10, 13,
and 21 dB. The remaining two patients’ thresholds
improved by 11 and 22 dB. Of these five patients with
changes 10 dB or more on mid-frequency (1, 2, and
4 kHz) hearing thresholds, only one was deemed to have
a clinically significant change over time (Fig. 2). Of note,
this patient was subsequently diagnosed with Alport
syndrome.
With only one clinically significant change over time,
the remaining 22 patients receiving serial audiograms
demonstrated clinically insignificant changes (Fig. 3).
The mean age in the 22 patients without any clinically
significant hearing changes was 9 years, compared with
5 years in the patient who worsened over time. Pure-tone
average (PTA) in patients whose mid-frequency hearing
thresholds remained constant was 42 dB, compared with
a PTA of 53 dB in the one MFSNHL patient experiencing
clinically worsened hearing thresholds (Table 2). As
shown in Table 2, average SRT in the worsening
MFSNHL patient was 43 dB, while average SRT in
the 22 patients with no clinical change in hearing was
29 dB. Average WRS in both groups was 92%. Average
change in mid-frequency (1, 2, and 4 kHz) hearing
thresholds in patients who remained constant was
1.0 dB, compared with a 21.0 dB in the patient whose
MFSNHL worsened over time.
DISCUSSION
This study demonstrates that only 4% of MFSNHL
patients with serial audiograms experienced clinically
significant worsening mid-frequency hearing thresholds
over time. This finding, while limited in sample size and
follow-up duration, demonstrates a stable level of hearing
after the initial hearing loss in almost all of our MFSNHL
patient population. Originally, five patients were thought
to have demonstrable changes in hearing thresholds with
time. However, after careful assessment of serial audio-
grams in these patients, only one of them experienced
true clinical worsening of mid-frequency hearing thresh-
olds. The changes in hearing thresholds in the remaining
four patients, deemed clinically insignificant are thought
FIG. 2. Baseline (X) and final (O) audiograms for the patient with worsening MFSNHL. X and O symbols do not represent left and right ear
audiograms. MFSNHL indicates mid-frequency sensorineural hearing loss.
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to be attributed to the test-retest variability inherent to all
audiograms and audiograms performed by different
audiologists. Careful examination of these clinically
insignificant changes included a return to baseline on
subsequent audiograms, improvement in one frequency
and decrease in an adjacent frequency, and change in air
conduction without changes in bone conduction.
Although the precise etiologies of our MFSNHL
cohort were not assessed, the variety of etiologies known
to cause MFSNHL may contribute to the reason why
MFSNHL can change over time. The stratification of
long-term outcomes of MFSNHL patients based on
etiology may offer enhanced granularity on the prognosis
of this patient cohort. The four genes identified that are
known to cause non-syndromic MFSNHL are TECTA
(encodes alpha-tectorin protein involved in tectorial
membrane) (8), COL11A2 (encodes for one of the two
alpha chain proteins in collagen XI) (9), CCDC50 (enc-
odes a protein ‘‘Ymer’’ known to be associated with the
inner ear) (8), and EYA4 (encodes EYA4 protein
involved in organ of corti maturation) (10). Of these
genes, there are seven loci known to cause MFSNHL.
Some mutations result in hearing loss pre-lingually (11–
17), while others affect hearing loss post-lingually that
can begin as late as the third decade of life (18–21).
Forms of autosomal dominant MFSNHL that began pre-
lingually have been demonstrated to be stable and not
progressive over time. In contrast, those who experience
hearing loss post-lingually demonstrate worsening
MFSNHL overtime (22). Thus, progression may be
dependent on the specific genetic mutation.
Another etiology of MFSNHL can be sudden onset
hearing loss that is not hereditary. These causes can be
attributed to various causes, including an idiopathic
nature or secondary to vestibular schwannoma, head
trauma, or infection. For instance, there are literature
reports of MFSNHL occurring after cordless telephone
injury, acoustic reflex test, or head trauma (23–25). In
patients with small vestibular schwannomas and
MFSNHL, progression slowly worsens (26). In Turner’s
syndrome, MFSNHL progresses with time to affect
higher frequencies (4). In contrast, one study showed
that patients with sudden onset MFSNHL of an idiopathic
nature improved after treatment with anti-viral medica-
tion and steroids (5). However, this study did not expand
far into the group of MFSNHL patients (n¼ 4) who
improved over time. These four patients were designated
as ‘‘U-shaped’’; however, this study did not mention the
degree of hearing loss or the hearing threshold difference
between low and high frequencies compared with mid-
frequencies used to definitively identify MFSNHL. In
our own experience of over 400 sudden hearing loss
patients, we have yet to experience a patient with
MFSNHL.
FIG. 3. Average baseline of all cookie bite audiograms included in study (X) and average of final audiograms in 22 patientswith unchanged
MFSNHL (O). X and O symbols do not represent left and right ear audiograms. MFSNHL indicates mid-frequency sensorineural
hearing loss.
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This study is the second to describe an MFSNHL
cohort and the first to demonstrate a primarily lack of
change in hearing loss as a function of time. The previous
study which had a higher mean age (35 yr) with reported
mid-frequency threshold means of 17 and 20 dB higher
than thresholds at 0.5 and 8 kHz did not provide results
over time (1). Although great care was taken to ensure the
accuracy and validity of this study, a number of limi-
tations exist. First, MFSNHL is rare, with only 37
patients meeting our inclusion criteria at a high-volume
audiology and neurotology center over the study period.
While more patients were tracked in this study compared
with the previous study by Shah et al. (1), it is likely the
sample size in our study is still limited in number.
Second, our patient population consisted of mainly pedi-
atric patients. This is significant because the test-retest
variability inherent to all audiograms is more evident in
pediatric patients (27). Moreover, audiograms were per-
formed by multiple audiologists at different times, caus-
ing some degree of test-retest variability. Furthermore,
the follow-up period in this study is limited to an average
of 3.7 years (median: 4 yr), which may not be long
enough to truly understand the long-term trajectory of
MFSNHL. This study can serve as the foundation for any
future follow-up of these patients for a longer period of
time to better understand this entity. Prospective studies
with longer follow-up periods are warranted to better
characterize the long-term outcomes of this patient pop-
ulation. Lastly, we were unable to identify the precise
etiology of each MFSNHL patient in our study. Better
delineation of etiology may better define why the one
patient in our study worsened.
CONCLUSION
The prognosis of MFSNHL is contingent, in part, upon
its diagnosed etiology and age of symptom onset. In our
study, 96% of MFSNHL patients experienced no clinical
progression of their hearing loss. We observed that, while
uncommon, it is possible for patients to experience
worsening MFSNHL and need hearing amplification in
the future. Long-term follow-up and better delineation of
the etiology of hearing loss in these patients may provide
better prognostic data to help with patient education.
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